Agence France Presse reports that US funding earmarked for an AIDS vaccine will fall off in 2006, forcing scientists to cooperate among themselves and with the private sector, a top government researcher said Monday.
CGD Policy Blogs
Today Michael Phillips brought the MCA to the front page of the Wall Street Journal. His article was an in-depth look at the first MCA compact with Madagascar, and the national dynamics that ushered this particular compact into being. He opened the article from Antananarivo with this:
A combination vaccine developed to reduce the number of injections infants receive appears to provide less immunity than the vaccines administered individually, according to a study in the April 13 2005 issue of JAMA.
Jim P. Buttery and colleagues conducted a study to determine the immunogenicity and safety of a combination 9-valent pneumococcal-group C meningococcal conjugate candidate vaccine.
The Infectious Diseases Society of America has published a report, Bad Bugs No Drugs, which calls for a range of incentives to encourage greater R&D into antibiotics for infectious diseases.
Jean-Francois Dehecq, Chairman and CEO of Sanofi-Aventis, set out the guiding principles of the group's policies on Access to Medicines at the BioVision conference.
The Group has identified 6 therapeutic areas for which concrete solutions can be envisioned: five curative therapeutic fields - malaria, leishmaniasis, sleeping sickness, tuberculosis and epilepsy - as well as the preventive field of vaccines.
According to the Voice of America, the head of UNAIDS, Peter Piot, says spending for HIV/AIDS programs in developing countries has increased from $200 million to more than $6 billion over the last eight years. Though he calls this encouraging, Dr. Piot says the big challenge is to get countries to make long-term commitments to funding to halt the spread of AIDS.
Africa needs more investment in research and manpower to boost vaccination rates that are less than half the global average, the director-general of the World Health Organization, Jong-Wook Lee, said on Wednesday.
Africa's vaccination coverage stood at around 30 percent, compared with a world coverage of more than 70 percent. The vaccines being used are also old. New investment is needed in research and development, but this is not really being done to a significant extent.
Here is the timetable, as far as we know it, for the G8 Summit in Gleneagles.
July 6-8, 2005
June 10-11, 2005
G7 Finance Ministers and Central Bank Governors Meeting, London
G7 Finance Ministers and Central Bank Governorns Meeting, Washington
Africa Partners Forum, Abuja, Nigeria